Beeta Biomed attends Collision Conference (2024).
Beeta Biomed attends the McGill Clinical Innovation Competition (2024).
Beeta Biomed’s QolorEX research is published in Nature Nanotechnology (2023).
Beeta Biomed participates in Startup Open House Montreal (2024).
Beeta Biomed attends the MEDTEQ+ Innovation Summit (2024).
McGill Health E-News publishes a feature on Beeta Biomed and QolorEX (2023).
Beeta Biomed’s CEO and CSO join the SelectUSA Select Global Women in Tech 2023 cohort (2023).
The McGill Innovation Fund awards Beeta Biomed with 50,000$ in non-dilutive funding (2022).
Dr. Sara Mahshid is interviewed live on CTV News Toronto about disease detection and QolorEX (2023).
Beeta Biomed recognized as a top 10 startup at the Innovobot Holiday Demo (2023).
Beeta Biomed has networking session with Roche Diagnostics (2023).
Beeta Biomed wins the McGill Engine’s William & Rhea Smith Award (2021).
Beeta Biomed attends Introduction to AIM: San Antonio Military Medical R&D (2024).
Beeta Biomed wins first-place in the SelectUSA Quebec Pitch Competition; attends the SelectUSA Investment Summit (2023).
Beeta Biomed is invited to meet with US Ambassador Cohen during SelectUSA Montreal (2023).
Beeta Biomed participates in the Regional Pitching Session at the SelectUSA Summit (2023).
Beeta Biomed attends Opportunities in Michigan for Quebec Companies (2023).
Beeta Biomed attends the HealthTech Ignite conference (2023).
Beeta Biomed presents QolorEX at CLIP Demo Day (2023).
Beeta Biomed wins the First-Place MI4 Innovation Prize at the McGill Clinical Innovation Competition (2022).